SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-23-015557
Filing Date
2023-09-07
Accepted
2023-09-07 17:00:30
Documents
28
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K cntg-20230630x6k.htm   iXBRL 6-K 37308
2 EX-99.1 cntg-20230630xex99d1.htm EX-99.1 70541
3 EX-99.2 cntg-20230630xex99d2.htm   iXBRL EX-99.2 455578
  Complete submission text file 0001558370-23-015557.txt   2547779

Data Files

Seq Description Document Type Size
4 EX-101.SCH cntg-20230630.xsd EX-101.SCH 30729
5 EX-101.CAL cntg-20230630_cal.xml EX-101.CAL 66678
6 EX-101.DEF cntg-20230630_def.xml EX-101.DEF 121672
7 EX-101.LAB cntg-20230630_lab.xml EX-101.LAB 268692
8 EX-101.PRE cntg-20230630_pre.xml EX-101.PRE 168815
22 EXTRACTED XBRL INSTANCE DOCUMENT cntg-20230630x6k_htm.xml XML 296039
Mailing Address AM STRANDE 7 ROSTOCK 2M 18055
Business Address AM STRANDE 7 ROSTOCK 2M 18055 49 30 2130 00325
Centogene N.V. (Filer) CIK: 0001757097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39124 | Film No.: 231242953
SIC: 8071 Services-Medical Laboratories